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Abstract 
Background: Extended spectrum β-lactamases (ESBLs), a group of enzymes conferring resistance to third generation 
cephalosporins have rapidly increased in Enterobacteriacae and pose a major challenge to human health care. Resist-
ant isolates are common in domestic animals and clinical settings, but prevalence and genotype distribution varies on 
a geographical scale. Although ESBL genes are frequently detected in bacteria isolated from wildlife samples, ESBL dis-
semination of resistant bacteria to the environment is largely unknown. To address this, we used three closely related 
gull species as a model system and collected more than 3000 faecal samples during breeding times in nine European 
countries. Samples were screened for ESBL-producing bacteria, which were characterized to the level of ESBL geno-
type groups (SHV, TEM), or specific genotypes (CTX-M).
Results: ESBL-producing bacteria were frequently detected in gulls (906 of 3158 samples, 28.7 %), with significant 
variation in prevalence rates between countries. Highest levels were found in Spain (74.8 %), The Netherlands (37.8 %) 
and England (27.1 %). Denmark and Poland represented the other extreme with no, or very few positive samples. 
Genotyping of CTX-M isolates identified 13 different variants, with blaCTX-M-1 and blaCTX-M-14 as the most frequently 
detected. In samples from England, Spain and Portugal, blaCTX-M-14 dominated, while in the rest of the sampled 
countries blaCTX-M-1 (except Sweden where blaCTX-M-15 was dominant) was the most frequently detected genotype, a 
pattern similar to what is known from studies of human materials.
Conclusions: CTX-M type ESBLs are common in the faecal microbiota from gulls across Europe. The gull ESBL geno-
type distribution was in large similar to published datasets from human and food-production animals in Europe. The 
data suggests that the environmental dissemination of ESBL is high from anthropogenic sources, and widespread 
occurrence of resistant bacteria in common migratory bird species utilizing urban and agricultural areas suggests that 
antibiotic resistance genes may also be spread through birds.
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Background
Nosocomial infections (in human clinics) with bacteria 
harboring extended spectrum beta-lactamase (ESBL) 
genes started to appear in Europe in the mid-1980s, and 
has since then constituted an increasing everyday chal-
lenge in European clinics [1, 2]. A shift in the prevalence 
and genotypes of ESBLs in Europe occurred around 2000, 
when the CTX-M type ESBLs became the dominating 
class, with much greater penetration into the Escherichia 
coli populations than TEM or SHV type ESBLs, and is 
now found in human outpatient settings [3]. Today more 
than 170 different CTX-M genotypes are described (Bush 
K, Palzkill T, Jacoby G. Lahey Clinic. http://www.lahey.
org/studies/, accessed September 2015), broadly divided 
in five groups (CTX-M group 1, 2, 8, 9 and group 25 
[4]). In humans the most common CTX-M variants are 
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blaCTX-M-14 and blaCTX-M-15 [3]. In food production ani-
mals ESBL-producing bacteria mainly occur in poultry, 
but are also reported with lower prevalence rates in cat-
tle and swine, with blaCTX-M-1, blaCTX-M-14, blaTEM-52 and 
blaSHV-12 as the currently most frequently reported geno-
types [5]. By comparing population genetic relationships 
between E. coli from humans and poultry it has been 
shown that antibiotic-resistant E. coli isolates are more 
frequently related than antibiotic-susceptible isolates are 
[5]. Further, a coherence between poultry and human 
ESBLs has been shown by sequence typed E. coli com-
parisons [6], illustrating transmission of resistant strains 
between sources. Consequently, both the clonality of E. 
coli and specific resistance genotypes are important study 
topics for fully understanding how transfer of resistance 
may occur. This is also concluded by Lazarus et  al. in a 
systematic review, finding that food production animals, 
more apparent for poultry, may constitute a source of 
human extraintestinal ESCR-EC (expanded-spectrum 
cephalosporin-resistant Escherichia coli) infections. [7].
Recently, the occurrence of ESBL-producing bacteria 
in the environment has started to receive more attention 
and it has repeatedly been shown that they are regularly 
found in both wildlife and the environment [8–12]. The 
level of ESBL-producing bacteria in the environment 
seems to be higher in areas with high human densities, 
but are also found in seemingly remote areas, including 
Escherichia coli of O25b-ST131 clone harboring blaCTX-
M-15 in gulls sampled at the isolated Commander Islands 
in Russia and 37 % ESBL harboring isolates in gulls sam-
pled in Barrow, Alaska [13, 14]. Thus, wildlife has been 
pointed out as a potential reservoir for resistant bacteria 
[9, 10], and especially species that live close to humans 
[15–17]. In recent years, gulls (Laridae) have become 
particularly studied since they have many characteris-
tics which make them suitable for resistance dissemi-
nation studies [11, 12, 18, 19]. Several gull species have 
large breeding distributions, are common in man-made 
environments, and to a large extent feed on human and 
food-animal waste. High carriage rates of ESBL-produc-
ing bacteria in gulls have been reported, for instance in 
a study from France where 9.4 % of the sampled Yellow-
legged gulls (Larus michaelis) harbored ESBL-producing 
bacteria [11], and two studies of gulls in Portugal where 
19.3 and 32  % of the gulls, respectively, carried ESBL-
producing bacteria [19, 20]. A problem when addressing 
resistance occurrence in wildlife bacteria is that studies 
have generally been small, or not utilized standardized 
methodologies [10]. In order to gain a broader view of 
the resistance situation in the environment we undertook 
a standardized study where >3000 fecal samples from 
gulls in nine European countries were screened for ESBL-
producing bacteria, with primary focus on prevalence of 
CTX-M genotypes. Specifically, we wanted to describe 
the occurrence and spatial variation in ESBL prevalence 
and blaCTX-M genotype distribution in Europe. If the 
occurrence of ESBL is primarily driven by transfer of 
resistant genotypes from humans and food-production 
animals into wildlife, we hypothesize that ESBL preva-
lence and genotype distributions would conform to pat-
terns seen in bacterial populations from these sources.
Methods
Studied avian species, sampling sites and sampling 
methodology
Fecal samples were collected from Herring gulls (Larus 
argentatus) and Lesser-Black backed gulls (Larus fuscus) in 
northern Europe, and Yellow-legged gulls (Larus michae-
lis) in southern Europe (Table  1; Fig.  1). Field sampling 
was conducted from mid-June to early July 2009 in nine 
European countries. From each of the 14 sampling sites, 
101–323 samples with bacterial growth were used (sam-
ple viability ensured by growth on non-selective media). 
Samples were collected from adult and subadult birds in or 
around breeding colonies. By collecting the samples dur-
ing the late breeding season we limited the risk of sampling 
non-stationary birds. The sampling areas were chosen to 
be as similar as possible according to human activities, but 
different human density, suitable sampling locations, etc. 
made it impossible to have completely identical sites. To 
avoid that multiple samples were collected from one bird, 
samples were collected from separated flocks, and with 
fewer samples than individuals present at each site.
Sterile cotton wool swabs were swirled in freshly 
deposited fecal material on the ground where gulls had 
recently been roosting. Swabs were put in tubes contain-
ing bacterial freeze medium [Luria broth; BD, Sparks, 
USA, phosphate buffered saline containing 0.45  % Na-
citrate, 0.1 % MgSO4, 1 % (NH4)2SO4, and 4.4 % glycerol] 
and immediately frozen in liquid nitrogen until arrival at 
the laboratory in Sweden where they were subsequently 
stored in −80 °C.
Isolation of ESBL‑producing bacteria
In total, 3158 fecal samples with bacterial growth (101–
323 samples/sampling site) were available for analysis 
(Table 1). All samples were enriched in brain heart infu-
sion broth (Becton–Dickinson, Franklin Lakes, NJ, USA), 
supplemented with 16  mg/L vancomycin, for 18–24  h 
in 37  °C, and subsequently inoculated on a ChromID™ 
ESBL plates (bioMérieux, Solna, Sweden), according 
to the manufacturer’s instructions. Presumptive ESBL 
producing colonies were isolated and species identity 
was confirmed by biochemical testing (standard fer-
mentation analysis such as lactose ferm., ONPG, Voges-
Proskauer, spot indole etc.) and MALDI/TOF (Bruker 
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Daltonik GmbH, Bremen Germany). ESBL plates with 
bacterial growth of more than one bacterial species each 
presumable species was isolated. ESBL-production was 
confirmed with the cefpodoxime/cefpodoxime +  clavu-
lanic acid double-disc test (MAST Diagnostics, Bootle, 
UK). Samples were regarded as ESBL producing and 
further analyzed when zone diameter around cefpodox-
ime was ≥5  mm than the zone diameter around cefpo-
doxime  +  clavulanic acid, according to manufacturer’s 
instructions (MAST Diagnostics, Bootle, UK).
Genetic determination of ESBL variants
The presence of blaCTX-M genotype was detected using a 
previously described multiplex real-time PCR protocol 
[21], allowing designation of CTX-M subgroups (CTX-M 
group 1, 2, 9 and 8/25) [21] using StepOnePlus™ real-
time PCR system (Applied biosystems). Positive isolates 
were sequenced using specific primers and protocols 
described previously [22, 23]. Sequencing was performed 
by Eurofins Genomics (Ebersberg, Germany).
The presence of blaTEM and blaSHV was detected using 
previously described primers [24] and a SYBR Green-
based real-time PCR protocol [12].
Results
Prevalence of ESBL producing bacteria
ESBL producing bacteria were detected in 906 (28.7 %) of 
the 3158 samples. Since 44 samples contained more than 
one ESBL-producing bacterial species, the total number 
of ESBL producing bacteria was 950 (Table 2). The vast 
majority of the isolated ESBL were E. coli (902 isolates, 
94.9 %) followed by 42 Klebisella (41 K. pneumoniae and 
one K. oxytoca) and only six isolates from other bacterial 
genera: Acinetobacter spp 1 (blaTEM,), Citrobacter spp 2 
(blaTEM+blaSHV), Enterobacter spp 2 (blaSHV) and Proteus 
spp 1 (blaCTX-M-2).
The levels of ESBL positive samples varied significantly 
between countries. In Spain 74.8 % of the total number 
of samples carried ESBL. Also, The Netherlands, England 
and Sweden had high levels of ESBL producing bacteria 
(37.8, 27.1 %, respectively 20.7 %), while only 0.8 % of the 
samples in Poland, and in Denmark no ESBL positive 
samples were detected at all (Table 2).
Distribution of ESBL variants
CTX‑M
In total, 602 (66.4 %) of the ESBL harboring isolates car-
ried CTX-M type ESBL. The number of detected blaCTX-
M variants was 13, distributed on five CTX-M group 1 
variants, one variant of CTX-M group 2, one variant of 
CTX-M group 8/25, and six variants of CTX-M group 
9 (Table 2). Group 1 (52.9 % of the total number of iso-
lated CTX-M) and group 9 (42.2 %) dominated, and only 
a few isolates were designated group 2 (4.7 %) and group 
8/25 (0.2  %) (Table  2). The most common genotypes 
were blaCTX-M-1 and blaCTX-M-14, but there was a large 
variation between blaCTX-M variants between countries 
(Table  2). In Spain, Portugal and England blaCTX-M-14 
was the most common CTX-M genotype. In The Neth-
erlands there was a large dominance of blaCTX-M-1 (76.6 % 
Table 1 Description of sampling sites and gull species
a Percentage (%) represents the frequency of a gull species in the sampled flocks when there was more than one species present in the flock
b Number of viable samples from each sampling site
Country Location Speciesa Samples (n)b Description
Denmark Blavand Larus fuscus (60 %) 158 Coastline close to Roskilde
Larus argentatus (40 %)
England Bristol Larus argentatus 133 Central Bristol
Ireland Howth Larus argentatus 266 Suburb of Dublin close to fishing habour
Latvia Daugava Larus argentatus 323 Close to central Riga
Kaltene Larus argentatus 101 Countryside 60 km SV Riga
Netherlands Borsele Larus argentatus 280 Industry habour
Rotterdam Larus fuscus (90 %) 280 Industry habour
Larus argentatus (10 %)
Poland Wladyslawowo Larus argentatus 280 Coastline close to Gdansk
Portugal Lagos Larus michaellis 314 Fish market in Lagos
Portimao Larus michaellis 111 Coastline close to Portimao
Spain Emporda Larus michaellis 199 Citydump outside Emporda
Mazarron Larus michaellis 321 Breeding colonie close to Mazarron
Malaga Larus michaellis 175 Harbour in Malaga
Sweden Hudiksvall Larus argentatus 217 Archipelago outside Hudiksvall
Page 4 of 8Stedt et al. Acta Vet Scand  (2015) 57:74 
of all CTX-M) while in Sweden blaCTX-M-15 (71.2  % of 
all CTX-M) was the most common. The CTX-M group 
2 (blaCTX-M-2) was only found in three countries, Latvia, 
The Netherlands and England, and corresponded to 32.5, 
7.8 and 3.4 % of the total number of CTX-M type ESBL, 
respectively. In Spain, one E. coli carried a blaCTX-M-8 
while no sample carried genotypes from CTX-M group 
25. A number of ESBL positive samples carried two dif-
ferent blaCTX-M genotypes and a great part of those that 
carried blaCTX-M were also positive for both blaTEM and/
or blaSHV (data not shown).
TEM and SHV
ESBL positive isolates were screened for blaTEM and 
blaSHV genotypes, but not sequenced for specific geno-
type variants. In total 222 isolates were blaTEM positive 
and 372 blaSHV positive. Of these, 216 (80  %) blaTEM 
and 242 (65  %) blaSHV were present in the same iso-
late as another ESBL genotype. In those isolates it is 
not possible to exclude the commonly appearing vari-
ants blaTEM-1, blaTEM-2 and blaSHV-1 which are not true 
ESBLs. Thus, the level of true ESBLs could be lower for 
these variants.
Fig. 1 Distribution of CTX-M groups in E. coli from gulls in the nine European countries. In Spain (Emporda) one sample included a CTX-M group 8 
(blaCTX-M-8) harboring isolate
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Discussion
Having investigated several of the European countries, 
particularly in the western parts, we can report a wide 
difference in ESBL prevalence, starting with none or very 
low ESBL prevalence in Denmark (0  %), Poland (0.7  %) 
and Ireland (4.5 %), to intermediate in Portugal (12.7 %), 
Latvia (17.4  %) and Sweden (20.7  %), and increasingly 
higher in England (27.1  %), The Netherlands (37.8  %), 
and Spain (74.8  %). Compared to current human clini-
cal or veterinary data, most countries investigated show 
a high level of acquired ESBL resistance. Despite that on 
a national level prevalence rates could vary considerably, 
to our knowledge, the rates of ESBL producing bacteria 
reported in this study are greater than any previous study 
of clinically relevant bacteria from a wildlife source.
Standardized European studies covering prevalence of 
ESBLs in E. coli among community isolates from healthy 
humans are limited and not always including geno-
type details [25]. For European coverage EARS-net has 
a yearly report presenting levels of bacteria with resist-
ance to third generation cephalosporins from clinical 
isolates [26]. In our study all countries except Denmark 
and Poland had ESBL levels higher then presented for 
clinical E. coli isolates from Europe in the corresponding 
countries, although AmpC was included in the Ears-net 
report and also the sample populations are very different. 
In countries such as Sweden and Spain, the levels of ESBL 
positive samples were considerably higher than reported 
from samples of healthy humans in separate studies in 
corresponding country [27–29]. Denmark and Poland 
were the only two countries that had lower prevalence 
in comparison to the data presented on EARS-net. From 
Denmark more recent data from 2011 presented by the 
DANMAPS yearly report show low but increasing lev-
els of ESBLs in clinical samples and ESBLs were found 
in almost 8 % of blood culture samples from hospitalized 
humans [30]. Also in Portugal the levels of ESBL from our 
gull samples were low in comparison to the neighboring 
Table 2 Description of ESBL harboring samples and blaCTX-M variants found in investigated countries
a Total number of ESBL genotypes (n) in each country. Note that some bacterial strains carried more than one ESBL genotype
b Percentage (%) of total number of samples carrying ESBL
c Percentage (%) of the total n the total number of ESBL in each country umber of ESBL in each country belonging to a certain genotype
d Percentage (%) of TEM and SHV of the total number of ESBL in each country. However, note that a blaTEM and blaSHV genotype present in the same bacterial strain as 
another ESBL genotype could be blaTEM-1, blaTEM-2, or blaSHV-1 which are not considered true ESBL genotypes, but the original genes from which later genotype variants 
are derived from
CTX‑M group Denmark England Ireland Latvia Poland Portugal Spain Sweden Nether‑
lands
Samples (n) 158 133 266 424 280 425 695 217 560
ESBL geno-
types (n)a
0 50 12 98 2 74 572 74 280
ESBL 
samples(%)b
(0) (27.1) (4.5) (17.4) (0.7) (12.7) (74.8) (20.7) (37.8)
1
 CTX-M-1 5.3c 2.6 4.2 0.4 1.4 3.2 2.3 21.3
 CTX-M-3 0.8 0.2 0.1 0.2
 CTX-M-15 4.5 0.4 3.5 0.5 1.3 13.8 2.1
 CTX-M-32 0.4 0.5 0.4 0.7 2.9 0.7
 CTX-M-55 0.2
2




 CTX-M-9 0.2 2.7 0.2
 CTX-M-14 8.3 2.4 16.8 0.9 1.4




 TEMd 3.0 0.7 6.6 26.2 3.6
 SHVd 12.0 1.1 10.1 5.6 27.8 14.7 17.9
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country Spain and a previously performed study on gulls 
from Portugal where ESBL was found in 32 % of the sam-
pled gulls [19].
Spain showed extremely high levels of ESBLs, and in 
Sweden which is known to have low level of ESBLs in 
humans [31], 20.7  % of the gulls carried ESBL. This is 
much higher than previously found in gull studies per-
formed in Sweden [12, 32]. The Netherlands have in 
coherence with Sweden low antibiotic usage in human 
clinical settings, but in gulls the levels were second high-
est when the studied countries are compared (37.8  %) 
[33]. However, The Netherlands have far higher antibiotic 
consumption in food-production [34].
Food-production animals are suggested to be an 
important source in the environmental dissemination of 
resistant bacteria, and the total consumption of antibiot-
ics is much higher than what is used by human medicine 
[35]. The most comprehensive data for antibiotic resist-
ance levels in food-production animals are presented for 
poultry, pigs and cattle in a yearly report by the European 
Food Safety Authority (EFSA). Compared to our study 
ESBL levels from seven of the countries are included 
(Denmark, England, Ireland, Latvia, Netherlands, Spain 
and Sweden). The levels of third generation cephalospor-
ins resistance from 2008 were very low (<1  %) in cattle 
and pigs for all included countries. In poultry the levels 
of resistant E. coli varied between 0 and 26  % [36]. The 
overall trends corresponded, with highest levels of ESBLs 
in E. coli found in Spain from poultry and from our sam-
pled gulls. Further ESBL was lacking in Danish poultry as 
well as the gull samples. Although trends should be the 
same, resistance levels may differ due to the randomized 
sampling approach used in the EFSA material.
In our gull material significant differences in genotype 
distributions could be seen between countries. In Spain, 
Portugal and England blaCTX-M-14 was dominant, while 
blaCTX-M-1 and blaCTX-M-15 was most frequently detected 
in the other surveyed countries (Table  2). This is in 
coherence with the human situation, where blaCTX-M-14 
followed by blaCTX-M-15 are the most common genotypes 
in humans while blaCTX-M-1 and blaCTX-M-14 are most fre-
quently detected in domestic animals [36, 37]. The pat-
tern seen in gull isolates is to large extent in coherence 
with the pattern of blaCTX-M genotype distribution in 
human isolates in Europe [3]. Livermore et  al. [3] have 
elegantly summarized CTX-M data from humans in 
Europe in a review article and here blaCTX-M-14 is noted 
as one of the most frequent genotypes in Spain which 
is in coherence with results. Further, a study on E. coli 
isolated at Spanish hospitals showed high similarity in 
genotype frequency with our results (52 % of all CTX-M 
was blaCTX-M-9 and 39  % blaCTX-M-14) [38]. Also in Por-
tugal and England there was a dominance of blaCTX-M-14 
in isolates from gulls which is not the situation in human 
isolates. Separate publications from humans in UK and 
Portugal, and also a previous study on gulls in Portugal, 
found that blaCTX-M-14 was scarce in these [19, 39, 40]. 
This contrast could be explained by sampling site devia-
tion from the “general picture”, or possibly dissemination 
from other sources as for example food-production ani-
mals. Studies show that blaCTX-M-14 genotype is frequent 
in Spanish and Portuguese poultry [41–43].
In England, Ireland and Sweden, included in our study, 
Livermore et  al. [3] reports blaCTX-M-15 as the most fre-
quently occurring genotype in isolates from humans and 
blaCTX-M-1 is also frequently occurring. This is in coher-
ence with our results where blaCTX-M-1 was dominant in 
each country except Sweden which showed a large domi-
nance of blaCTX-M-15. Interestingly, blaCTX-M-15, which 
is the dominating variant in humans in many parts of 
Europe, was not common in samples from gulls, except 
in those sampled in Sweden. This is another example of 
overlapping patterns between observations in wild birds 
and in humans, as blaCTX-M-15 is also the most common 
CTX-M variant in humans in Sweden [3, 44].
In contrast, The Netherlands where the human 
antibiotic consumption in humans are comparable 
to Sweden but far higher in food-production animals 
there was a total dominance of blaCTX-M-1 [34]. This is 
considered as a CTX-M genotype most often found in 
poultry and other food-production animals in Europe 
[45, 46] and the poultry production in The Nether-
lands is the most intense in Europe [47]. High similari-
ties between ESBL variants in humans and poultry in 
the Netherlands have been seen with a dominance of 
blaCTX-M-1 [6].
The CTX-M group 2 is unevenly distributed in Europe, 
with different variants mainly spread in Russia and East-
ern Europe [2]. This pattern was seen in the gull material 
where 32  % of the CTX-M isolated from E. coli in Lat-
via belonged to blaCTX-M-2. It is also noteworthy that one 
blaCTX-M-8 was isolated from a gull E. coli in Spain, to our 
knowledge the first record of blaCTX-M-8 from wildlife [9].
Conclusions
Despite low availability of easily comparable data from 
human and veterinary settings, levels of ESBL are seem-
ingly higher in wild gulls in some regions of Europe. 
Certainly, the diet of gulls make them exposed to a vari-
ety of bacteria from different sources. Gulls are gregari-
ous, especially during breeding, which could contribute 
to rapid spread of ESBL between individuals in a local 
population. Spread between gulls could also be medi-
ated by the environment, as shown for Salmonella which 
can be maintained in a breeding colony of gulls between 
breeding seasons [48]. Since many gull species migrate, 
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sometimes even between continents, there is a risk that 
these birds will contribute to the global spread of anti-
biotic resistance genes. The results from this study are 
therefore remarkable and the high environmental ESBL 
levels, as seen in gull fecal samples, alarming.
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